Time to recurrence · people with recurrent corneal erosion syndrome without other corneal basement membrane dystrophy
1 finding from 1 review
Recurrences requiring further treatment · people with recurrent corneal erosion syndrome without other corneal basement membrane dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptoms (pain score) · people with recurrent corneal erosion syndrome without other corneal basement membrane dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrence after complete or partial resolution · people with recurrent corneal erosion syndrome without previous surgical intervention
It is very uncertain whether therapeutic contact lens changes recurrence after complete or partial resolution compared with topical lubrication (very low certainty).
1 finding from 1 review
Adverse effects: corneal haze · people with recurrent corneal erosion syndrome without other corneal basement membrane dystrophy
1 finding from 1 review
Adverse effects: astigmatism · people with recurrent corneal erosion syndrome without other corneal basement membrane dystrophy
1 finding from 1 review
Time to recurrence · people with recurrent corneal erosion syndrome without previous surgical intervention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrences requiring further treatment · people with recurrent corneal erosion syndrome without previous surgical intervention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptoms (pain score) · people with recurrent corneal erosion syndrome without previous surgical intervention
1 finding from 1 review
Adverse effects: corneal haze · people with recurrent corneal erosion syndrome without previous surgical intervention
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Adverse effects: astigmatism · people with recurrent corneal erosion syndrome without previous surgical intervention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Resolution of symptoms · people with recurrent corneal erosion syndrome without previous surgical intervention
Phototherapeutic keratectomy showed no clear difference in resolution of symptoms after treatment compared with alcohol delamination (low certainty).
1 finding from 1 review
Recurrence after complete or partial resolution · people with recurrent corneal erosion syndrome without previous surgical intervention
Phototherapeutic keratectomy showed no clear difference in recurrence after complete or partial resolution compared with alcohol delamination (low certainty).
1 finding from 1 review
Improvement in ocular motility (ocular alignment ≤ 10 prism dioptres). · people with sixth nerve palsy
Botulinum toxin showed no clear difference in improvement in ocular motility (ocular alignment ≤ 10 prism dioptres). compared with observation (low certainty).
1 finding from 1 review
Secondary outcome: achievement of binocular single vision · people with sixth nerve palsy
Botulinum toxin showed no clear difference in achievement of binocular single vision (fusion and stereopsis… compared with observation (low certainty).
1 finding from 1 review
Improvement in functional ability · people with sixth nerve palsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · people with sixth nerve palsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events. · people with sixth nerve palsy
1 finding from 1 review
Intervention not reported
Gabapentin up to 900 mg/day) versus baclofen (up to 30 mg/day). · people with acquired nystagmus
1 finding from 1 review
Intervention not reported
3,4‐DAP (20 mg, single dose) versus placebo. Assessments made 30 minutes after taking the drug or placebo · people with acquired nystagmus
1 finding from 1 review